Arun Iyer

Arun Iyer, PhD, currently serves as the Director of Strategic Partnering in Business Development and Licensing at Boehringer Ingelheim, where responsibilities include evaluating technologies and collaborations in virology, bacteriology, and vaccine development within the Animal Health sector. Prior experience includes roles as Senior Scientist and Scientist IV at Boehringer Ingelheim, focusing on virology and vaccine development. Previous positions as a postdoctoral researcher at Mount Sinai School of Medicine and Louisiana State University involved significant contributions to the development of universal influenza vaccines and antivirals. Arun Iyer holds a PhD in Vaccinology/Virology/Immunology from Louisiana State University and multiple degrees in related fields from The University of Texas at Austin and the University of Mumbai, showcasing a comprehensive background in microbial genetics and vaccine research.